Xeris Biopharma (XERS) AI Analysis
XERS$16.80—
Market cap$3.10BEnterprise value—Revenue (TTM)$368.26MMarket position—
Score
65
Bullish
Value
32
Quality
70
Growth
94
Xeris Biopharma Holdings is a growth-led story right now — Growth 94/100 is the pillar doing the heavy lifting (overall 65/100) in Biotechnology. Under the hood: revenue compounding ~39% annually over recent years. Street targets still imply ~11% below the current price.